Clinical Trials Directory

Trials / Completed

CompletedNCT01465620

Dietetic and Hygiene Measures in Metabolic Neuropathies: the Neurodiet Study

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
8 (actual)
Sponsor
Henri Mondor University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Metabolic disorders such as diabetes mellitus, glucose intolerance and possibly metabolic syndrome can induce a peripheral neuropathy. To investigate the effect of physical training and diet education on neuropathic symptoms and neurophysiological parameters of patients with metabolic neuropathies.

Detailed description

Metabolic disorder such as diabetes mellitus, glucose intolerance and possibly metabolic syndrome can induce a peripheral neuropathy. The objectives of the present study are to investigate: 1. the effect of physical training and diet education on neuropathic symptoms and neurophysiological parameters 2. the best coaching modality of education. This will be a prospective single blind study (blinded evaluator). Patients will be randomly assigned in two groups. The first group will have a one-day therapeutic education program followed by a 5-minutes phone call every week for 3 months. The second group will have the same one-day therapeutic education program that will be followed by an unique one-hour phone call. During the one-day therapeutic education program and the phone calls, hygienic rules (ie physical activities) and dietetic regimen advices will be given to patients. Evaluation will be done at 3 months.

Conditions

Interventions

TypeNameDescription
BEHAVIORALhygienic-dietetic measuresTherapeutic education about hygienic-dietetic measures followed by a 5 minutes phone call per week during 3 months
BEHAVIORALhygienic-dietetic measuresTherapeutic education about hygienic-dietetic measures followed by only one phone call

Timeline

Start date
2011-11-01
Primary completion
2018-06-01
Completion
2018-06-01
First posted
2011-11-07
Last updated
2018-08-29

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01465620. Inclusion in this directory is not an endorsement.